ArticleBiomedicines2021

Development and Characterization of a Novel Peptide-Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors.

Yayu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.